Peter G. Mortimer

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

Jeeyun Lee, Seung Tae Kim, Kyung Kim et al. · Cancer Discovery · 2019 · 234 citations

Medicine, Oncology, Pharmacology +17

A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>

Peter G. Mortimer, Laura J. V. Piddock · Journal of Antimicrobial Chemotherapy · 1991 · 176 citations

Life Sciences, Microbiology, Pharmacology +11

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

R. Kim, Minsuk Kwon, Minae An et al. · Annals of Oncology · 2021 · 115 citations · Full text

Medicine, Oncology, Pharmacology +16

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Malcolm Ranson, Peter Hersey, D.M. Thompson et al. · Journal of Clinical Oncology · 2007 · 110 citations

Medicine, Oncology, Pharmacology +10